Efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine green frluorsecence guidance

Efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine green frluorsecence guidance - Efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine green frluorsecence guidance

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs051180087

Enrollment

Registered

2019-03-04

Start date

2017-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oralcanser oral canser

Interventions

Use 3D-CT lymphography and an indocyanine green frluorsecence guidance

oral canser

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with previously untreated cTxN0M0 oral cancer who wasevaluated with clinical examination,ulutrasound ,CT,and or MRI,are the canditates for our stady. Patients no having in history of previous head and neck canser,no allergy to iodne, shelfisy and ICG.

Exclusion criteria

Exclusion criteria: A history of radiation therapy to neck,or head and neck cancer pregnancy or lactating woman ,or woman with suspected pregnancy

Design outcomes

Primary

Measure	Time frame
Identification rate of sentinellymph node by using 3D-CT lymphography and ICG fluorescence guidance.	—

Secondary

Measure	Time frame
False negative rate of sentinel lymph node 2.Relations between BMI and identification rate of lymph node.	—

Contacts

Public ContactOsamu Ishihara

Osaka general medical center

ishihara@gh.opho.jp+81-666921201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026